Independent Preclinical Review · United States
Observation before conclusion.
An independent editorial examination of preclinical peptide literature, experimental models, methodology, replication, and the distance between an observation and a claim.
Preclinical models · General education · Not medical advice
Evidence Review · Feature
A finding can appear repeatedly in search results while still tracing back to a narrow experimental lineage. We follow the BPC-157 tendon literature back to its roots and ask what repeated citation actually demonstrates — and what it cannot.
A gastric pentadecapeptide whose rodent literature is broad, repetitious, and rarely independent.
An actin-binding peptide with a fragmented preclinical record across wound and cardiac models.
A copper tripeptide studied mostly in skin fibroblasts, wound models, and cosmetic-adjacent research.
An α-MSH fragment examined in murine colitis models and cultured intestinal epithelium.
The Publication
BENCHLINE reads preclinical peptide research the way it was produced: one model, one endpoint, one laboratory at a time. We record species, sample size, blinding, and lineage before we record conclusions, because in this literature the conclusion is usually the least stable part of the paper.
The publication covers experimental models and evidence quality. It does not cover dosing, sourcing, purchasing, or human use, and it accepts no advertising, sponsorships, or affiliate arrangements of any kind.
“An observation becomes a conclusion only after surviving everything that could have made it misleading.”
BENCHLINE · Editorial position
How many animals, wells, or sections actually carried the result — and whether the count appears before the claim or after it.
Whether allocation and assessment were protected from expectation, or whether the methods section is silent on both.
Whether a finding has been reproduced by laboratories outside the lineage that first reported it. Repeated citation is not replication.
What was measured, when it was chosen, and whether the endpoint reported is the endpoint the experiment was built around.
Newsletter
New essays and evidence reviews, roughly twice a month. Free, and free of marketing.
